What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in Q2 2023?

267 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 135,488,140
Total 13F shares: 71,799,685
Share change: -638,974
Total reported value: $2,559,646,627
Put/Call ratio: 86%
Price per share: $35.66
Number of holders: 267
Value change: -$10,508,327
Number of buys: 117
Number of sells: 132

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 04280A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.4%	12,710,801	$322,854,345	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	7.9%	10,687,871	$271,471,923	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	4.4%	5,902,768	$149,930,307	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	2.1%	2,909,965	$73,913,000	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	1.6%	2,180,793	$55,392,142	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	2,078,527	$52,794,603	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	1.3%	1,741,300	$44,229,020	—	31 Mar 2023	13F
Rokos Capital Management LLP	13F	Company	1.2%	1,675,921	$41,537,702	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	1%	1,387,086	$35,231,983	—	31 Mar 2023	13F
FMR LLC	13F	Company	1%	1,373,247	$34,880,464	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.97%	1,319,992	$33,527,796	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.93%	1,257,545	$31,941,643	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.85%	1,157,575	$29,402,405	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.77%	1,039,993	$26,415,822	—	31 Mar 2023	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.76%	1,025,654	$26,051,611	—	31 Mar 2023	13F
Aquilo Capital Management, LLC	13F	Company	0.75%	1,018,474	$25,869,240	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.72%	969,394	$24,623,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.63%	848,305	$21,546,947	—	31 Mar 2023	13F
Western Financial Corp/CA	13F	Company	0.61%	820,320	$20,836,128	—	31 Mar 2023	13F
NOMURA HOLDINGS INC	13F	Company	0.56%	761,147	$19,333,134	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.53%	712,591	$18,099,812	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.47%	642,057	$16,308,716	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.47%	634,268	$16,110,409	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.44%	592,238	$15,042,845	—	31 Mar 2023	13F
Commodore Capital LP	13F	Company	0.42%	575,000	$14,605,000	—	31 Mar 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.4%	536,965	$13,638,911	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.35%	475,767	$12,084,482	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.34%	466,278	$11,843,474	—	31 Mar 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.33%	444,017	$11,278,032	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.33%	443,684	$11,269,573	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.31%	423,307	$10,751,998	—	31 Mar 2023	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.31%	416,005	$10,566,000	—	31 Mar 2023	13F
E. Ohman J:or Asset Management AB	13F	Company	0.29%	392,117	$9,959,772	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.26%	352,714	$8,958,936	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.25%	345,485	$8,775,000	—	31 Mar 2023	13F
Retirement Systems of Alabama	13F	Company	0.25%	334,720	$8,501,888	—	31 Mar 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.24%	330,658	$8,398,713	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.23%	315,982	$8,025,943	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.22%	303,186	$7,700,924	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.22%	299,342	$7,603,286	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.22%	292,800	$7,437,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.2%	277,226	$7,041,000	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.2%	275,788	$7,005,015	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.21%	288,054	$6,734,384	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.19%	262,431	$6,665,747	—	31 Mar 2023	13F
Privium Fund Management B.V.	13F	Company	0.19%	259,036	$6,579,514	—	31 Mar 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.18%	250,581	$6,364,757	—	31 Mar 2023	13F
JOHNSON & JOHNSON	13F	Company	0.18%	247,598	$6,288,989	—	31 Mar 2023	13F
Neuberger Berman Group LLC	13F	Company	0.18%	246,190	$6,253,226	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.18%	244,441	$6,208,801	—	31 Mar 2023	13F

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q2 2023

As of 30 Jun 2023, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 267 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,799,685 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, FMR LLC, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, Rokos Capital Management LLP, CREDIT SUISSE AG/, and NORTHERN TRUST CORP. This page lists 268 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

250

Q2 2023 holders

267

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.